Amarin Corp PLC (NAS:AMRN)
$ 0.704 -0.0208 (-2.93%) Market Cap: 289.25 Mil Enterprise Value: -10.54 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 43/100

Amarin Corporation plc - Special Call Transcript

Mar 30, 2020 / 09:30PM GMT
Release Date Price: $13.58 (+2.57%)
Operator

Welcome to Amarin Corporation's conference call to discuss select scientific publications from the American College of Cardiology's 69th Annual Scientific Session together with the World Congress of Cardiology. This conference call is being recorded today, March 30, 2020.

I will now turn the conference call over to Elisabeth Schwartz, Senior Director of Investor Relations of Amarin. Please go ahead.

Elisabeth Schwartz
Amarin Corporation plc - Senior Director of IR

Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the American College of Cardiology's 69th Annual Scientific Session together with World College of -- Congress of Cardiology. To level set expectations, we will be limiting this session to scientific matters directly presented during the recently completed ACC meeting. We'll not be discussing business matters, including Amarin's ANDA litigation or any matters

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot